Privately held $1 billion dollar Japanese OTC, Medical and Pharmaceutical manufacturer, distributor and licensor of leading brands and products for drugstores. Kobayashi was looking to enter U.S. market and also move U.S. branded products into its pipeline in Asia. Arich identified major U.S. consumer brands for review by CEO and New Product Team in Japan for licensing deals, joint-venture, import, master distribution and technology transfer. Managed all relationships from initial contact through deal completion, developing distribution and import deals with Block Drugs and other major HBA manufacturers to move products into Japan.
Result: Generated over $100 million in annual volume for American consumer products in Japan, including Sweet ‘N Low, Kendall Futuro, Blistex, Lysol, Odor Eater, and Polident/Poligrip.